These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 1680767)

  • 1. [Growth factors of enterochromaffin-like cells and physiopathology of experimental carcinoid tumors].
    Tielemans YK; Willems GE
    Gastroenterol Clin Biol; 1991; 15(5 ( Pt 2)):24C-29C. PubMed ID: 1680767
    [No Abstract]   [Full Text] [Related]  

  • 2. [From acid secretion inhibition to enterochromaffin-like cell proliferation. Traps on the path].
    Bonfils SJ
    Gastroenterol Clin Biol; 1991; 15(5 ( Pt 2)):59C-64C. PubMed ID: 1916120
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of endogenous and exogenous gastrin on enterochromaffin-like cell proliferation].
    Tielemans YK; Willems GE
    Gastroenterol Clin Biol; 1991; 15(5 ( Pt 2)):19C-23C. PubMed ID: 1916115
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of a gastrin/cholecystokinin B receptor antagonist, S-0509, on the omeprazole-induced proliferation of gastric mucosa in rats.
    Ono M; Sato H; Kazumori H; Yuki M; Rumi MA; Ortega-Cava CF; Ishihara Y; Ishihara S; Adachi K; Kinoshita Y
    J Lab Clin Med; 2003 Dec; 142(6):364-71. PubMed ID: 14713888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced hyperplasia of gastric enterochromaffinlike cells in response to omeprazole-evoked hypergastrinemia in rats with portacaval shunts. An immunocytochemical and chemical study.
    Axelson J; Ekelund M; Sundler F; Håkanson R
    Gastroenterology; 1990 Sep; 99(3):635-40. PubMed ID: 2379770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of omeprazole-evoked hypergastrinemia on ultrastructure of enterochromaffin-like cells in the stomach of portacaval-shunted rats.
    Chen D; Håkanson R; Sundler F
    Cell Tissue Res; 1993 Apr; 272(1):71-7. PubMed ID: 8481958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The gastrin hypothesis. Implications for antisecretory drug selection.
    Karnes WE; Walsh JH
    J Clin Gastroenterol; 1990; 12 Suppl 2():S7-12. PubMed ID: 2246496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do neuroendocrine cells, particularly the D-cell, play a role in the development of gastric stump cancer?
    Waldum HL; Haugen OA; Brenna E
    Cancer Detect Prev; 1994; 18(6):431-6. PubMed ID: 7867015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unilateral vagal denervation suppresses omeprazole-induced trophic effects on the denervated side of the rat stomach.
    Håkanson R; Axelson J; Tielemans Y; Johansson AG; Willems G; Sundler F
    Scand J Gastroenterol; 1992; 27(1):65-70. PubMed ID: 1736345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of long-term treatment with gastric acid antisecretory agents on the fundic mucosa].
    Cadiot G; Lehy T
    Ann Pathol; 1996; 16(2):81-90. PubMed ID: 8767673
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gastrin concentration in the blood and stomach tissue and the number of gastric endocrine cells after secretin administration].
    Fokina AA; Barashkova GM; Kotel'nikova VI; Boĭko NS
    Fiziol Zh SSSR Im I M Sechenova; 1982 May; 68(5):639-42. PubMed ID: 7095198
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mucosa of the gastric fundus and antisecretory agents].
    Diébold MD; Zeitoun P
    Ann Pathol; 1996; 16(2):75-7. PubMed ID: 8767671
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anomalies of fundic argyrophil cell proliferation (enterochromaffin-like cells) in Zollinger-Ellison syndrome].
    Cadiot G; Lehy T; Ruszniewski P; Sobhani I; Vallot T; Mignon M
    Gastroenterol Clin Biol; 1991; 15(5 ( Pt 2)):41C-46C. PubMed ID: 1916118
    [No Abstract]   [Full Text] [Related]  

  • 14. Gastric morphological changes including carcinoid tumors in animals treated with a potent hypolipidemic agent, ciprofibrate.
    Spencer AJ; Barbolt TA; Henry DC; Eason CT; Sauerschell RJ; Bonner FW
    Toxicol Pathol; 1989; 17(1 Pt 1):7-15. PubMed ID: 2501865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypergastrinemia and gastric enterochromaffin-like cells.
    Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
    Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell and tumour biology of the gastric enterochromaffin-like cell.
    Modlin IM; Tang LH
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S117-30. PubMed ID: 10604115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrin--a normal and pathologic regulator of gastric function.
    Walsh JH
    West J Med; 1991 Jan; 154(1):33-5. PubMed ID: 2024507
    [No Abstract]   [Full Text] [Related]  

  • 18. ECL-cell derived gastric cancer in male cotton rats dosed with the H2-blocker loxtidine.
    Fossmark R; Martinsen TC; Bakkelund KE; Kawase S; Waldum HL
    Cancer Res; 2004 May; 64(10):3687-93. PubMed ID: 15150129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential hazards of long-term acid suppression.
    Selway SA
    Scand J Gastroenterol Suppl; 1990; 178():85-92. PubMed ID: 1980549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion.
    Gilligan CJ; Lawton GP; Tang LH; West AB; Modlin IM
    Am J Gastroenterol; 1995 Mar; 90(3):338-52. PubMed ID: 7872269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.